相关实验视频
Updated: Jun 29, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
在多发性硬化症疾病的发展过程中,我们将注意力转移到早期
Samantha E Epstein1, Erin E Longbrake
1Department of Neurology, Yale University, New Haven, Connecticut, USA.
Current opinion in neurology
|March 28, 2024
概括
多发性硬化症 (MS) 的早期诊断至关重要. 研究正在推动临床前MS的鉴定和治疗,包括放射性隔离综合征 (RIS),以改善患者的治疗结果.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
- 临床神经科学 临床神经科学
背景情况:
- 多发性硬化症 (MS) 诊断标准的修订允许更早的检测.
- 早期诊断和治疗开始与改善的临床结果相关.
- 焦点正在转向最早的阶段:MS前体和放射性隔离综合征 (RIS).
研究的目的:
- 审查目前对临床前多发性硬化症 (MS) 的理解.
- 讨论管理临床前MS患者的方法.
- 突出最近在识别和治疗早期多发性硬化症阶段的进展.
主要方法:
- 对临床前多发性硬化症,前期性硬化症和RIS的当前文献的综述.
- 对临床试验和诊断标准修订的最新发现进行分析.
- 专家理解和临床方法的综合.
主要成果:
- 放射性隔离综合征 (RIS) 是最具特征的临床前多发性硬化症阶段.
- 修订后的RIS诊断标准确定了高风险患者.
- 治疗RIS的治疗干预可以延迟或预防临床MS发病.
结论:
- 在了解临床前多发性硬化症方面取得了进展,但需要系统地识别有风险的患者.
- 高风险RIS患者的预防疗法显示出潜力,但需要进一步的研究和共识.
- 持续的研究对于优化早期多发性硬化症的管理至关重要.
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469

